RS
Therapeutic Areas
BioGene Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Undisclosed bLNP-Gene Therapy | Diabetes (Type 1/2) | Preclinical |
Leadership Team at BioGene Therapeutics
DF
Dr. Francis Tavares, PhD.
Chief Technology Officer
DK
Dr. Kamal Albarazanji
Senior Director of Metabolic Research